Frequency and level of self-efficacy predict the effectiveness of therapist- and self-guided exposure in obsessive compulsive disorder.


Journal

Behavioural and cognitive psychotherapy
ISSN: 1469-1833
Titre abrégé: Behav Cogn Psychother
Pays: United States
ID NLM: 9418292

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 21 8 2020
medline: 21 11 2020
entrez: 21 8 2020
Statut: ppublish

Résumé

While exposure and response prevention (ERP) is the most effective treatment for obsessive compulsive disorder (OCD), less is known about the specific mechanisms underlying symptom change after ERP. We tested the hypothesis that the frequency of self- and therapist-guided ERP related to the extent of symptom reduction and that this link is mediated by increased self-efficacy. In a sample of 377 in-patients with a primary diagnosis of OCD receiving in-patient CBT, we assessed symptoms (YBOCS-SR) and self-efficacy (General Self-Efficacy Scale), before and after treatment, as well as the frequency of therapist- and self-guided ERP sessions. Patients with more therapist-guided ERP sessions during treatment showed more symptom reduction and the association of self-guided ERP on outcome was mediated by enhanced self-efficacy. These findings highlight the importance of both therapist- and self-guided ERP sessions and suggest that therapists should conduct a sufficient number of ERP sessions to optimise treatment.

Sections du résumé

BACKGROUND BACKGROUND
While exposure and response prevention (ERP) is the most effective treatment for obsessive compulsive disorder (OCD), less is known about the specific mechanisms underlying symptom change after ERP.
AIMS OBJECTIVE
We tested the hypothesis that the frequency of self- and therapist-guided ERP related to the extent of symptom reduction and that this link is mediated by increased self-efficacy.
METHOD METHODS
In a sample of 377 in-patients with a primary diagnosis of OCD receiving in-patient CBT, we assessed symptoms (YBOCS-SR) and self-efficacy (General Self-Efficacy Scale), before and after treatment, as well as the frequency of therapist- and self-guided ERP sessions.
RESULTS RESULTS
Patients with more therapist-guided ERP sessions during treatment showed more symptom reduction and the association of self-guided ERP on outcome was mediated by enhanced self-efficacy.
CONCLUSIONS CONCLUSIONS
These findings highlight the importance of both therapist- and self-guided ERP sessions and suggest that therapists should conduct a sufficient number of ERP sessions to optimise treatment.

Identifiants

pubmed: 32814601
pii: S1352465820000582
doi: 10.1017/S1352465820000582
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

751-755

Auteurs

Ulrich Voderholzer (U)

University of Freiburg, Department for Psychiatry and Psychotherapy, Hauptstrasse 5, 79104Freiburg, Germany.
Schön Clinic Roseneck, Am Roseneck 6, 83209Prien am Chiemsee, Germany.

Sven Hilbert (S)

University of Munich (LMU), Department of Methodology and Diagnostics, Leopoldstrasse 13, 80802Munich, Germany.

Anne Fischer (A)

University of Munich (LMU), Department of Methodology and Diagnostics, Leopoldstrasse 13, 80802Munich, Germany.

Jakob Neumüller (J)

University of Munich (LMU), Department of Psychiatry and Psychotherapy, Nußbaumstrasse 7, 80336Munich, Germany.

Caroline Schwartz (C)

University of Munich (LMU), Department of Psychiatry and Psychotherapy, Nußbaumstrasse 7, 80336Munich, Germany.

Johannes Baltasar Hessler-Kaufmann (JB)

Schön Clinic Roseneck, Am Roseneck 6, 83209Prien am Chiemsee, Germany.
University of Munich (LMU), Department of Psychiatry and Psychotherapy, Nußbaumstrasse 7, 80336Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH